Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Dulaglutide only product in parenteral dose form |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Ticagrelor 60 mg oral tablet |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Ticagrelor 60 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Crisaborole 20 mg/g cutaneous ointment |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Crisaborole 20 mg/g cutaneous ointment |
Has concentration strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Ixekizumab 80 mg/mL solution for injection |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Ixekizumab 80 mg/mL solution for injection |
Has concentration strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Minocycline (as minocycline hydrochloride) 15 mg/g cutaneous foam |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Minocycline (as minocycline hydrochloride) 15 mg/g cutaneous foam |
Has concentration strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Dupilumab 150 mg/mL solution for injection |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Dupilumab 150 mg/mL solution for injection |
Has concentration strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Dupilumab 175.439 mg/mL solution for injection |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Dupilumab 175.439 mg/mL solution for injection |
Has concentration strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Secukinumab 150 mg/mL solution for injection |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Secukinumab 150 mg/mL solution for injection |
Has concentration strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Fenfluramine 2.2 mg/mL oral solution |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Fenfluramine 2.2 mg/mL oral solution |
Has concentration strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Sofosbuvir 200 mg and velpatasvir 50 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Sofosbuvir 200 mg and velpatasvir 50 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
2 |
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Sofosbuvir 400 mg and velpatasvir 100 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
2 |
Bedaquiline (as bedaquiline fumarate) 20 mg oral tablet |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Bedaquiline (as bedaquiline fumarate) 20 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Bedaquiline (as bedaquiline fumarate) 100 mg oral tablet |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Bedaquiline (as bedaquiline fumarate) 100 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Monomethyl fumarate 95 mg oral capsule |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Monomethyl fumarate 95 mg oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Monomethyl fumarate only product |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Monomethyl fumarate only product in oral dose form |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution |
Has concentration strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution |
Has concentration strength denominator value |
False |
1 |
Inferred relationship |
Some |
2 |
Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution |
Has concentration strength denominator value |
False |
1 |
Inferred relationship |
Some |
3 |
Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution |
Has concentration strength denominator value |
False |
1 |
Inferred relationship |
Some |
4 |
Elagolix sodium 300 mg oral capsule |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Elagolix sodium 300 mg oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Elagolix sodium 300 mg and estradiol 1 mg and norethisterone 500 microgram oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Elagolix sodium 300 mg and estradiol 1 mg and norethisterone 500 microgram oral capsule |
Has presentation strength numerator value |
False |
1 |
Inferred relationship |
Some |
2 |
Elagolix sodium 300 mg and estradiol 1 mg and norethisterone 500 microgram oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
2 |
Elagolix sodium 300 mg and estradiol 1 mg and norethisterone 500 microgram oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
3 |
Clostridium histolyticum collagenase 900 microgram lyophilised powder for solution for injection vial |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Clostridium histolyticum collagenase 900 microgram lyophilised powder for solution for injection vial |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid only vaccine product |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated only vaccine product |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Minocycline only product in cutaneous dose form |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Fenfluramine only product in oral dose form |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Remdesivir 5 mg/mL solution for injection |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Remdesivir 5 mg/mL solution for injection |
Has concentration strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Soya bean oil refined only product in parenteral dose form |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Soya bean oil refined only product |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Ethanol 0.7 mL/mL cutaneous solution |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Ethanol 0.7 mL/mL cutaneous solution |
Has concentration strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Agomelatine (as agomelatine citric acid) 25 mg oral tablet |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Agomelatine (as agomelatine citric acid) 25 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Carbon (13-C) urea only product |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Carbon (13-C) urea only product in oral dose form |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens only vaccine product |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens only vaccine product |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Streptococcus pneumoniae Danish serotype 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated only vaccine product |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Inactivated whole Influenza A virus subtype H5N1 antigen only vaccine product |
Count of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Inactivated whole Influenza A virus subtype H5N1 antigen only vaccine product |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
SARS-CoV-2 antigen vaccine |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Bamlanivimab only product |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Bamlanivimab only product in parenteral dose form |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
SARS-CoV-2 mRNA vaccine |
Count of base of active ingredient |
False |
1 |
Inferred relationship |
Some |
|
Cyclizine tartrate 50 mg/mL and morphine tartrate 10 mg/mL solution for injection |
Has concentration strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Cyclizine tartrate 50 mg/mL and morphine tartrate 10 mg/mL solution for injection |
Has concentration strength denominator value |
False |
1 |
Inferred relationship |
Some |
2 |
Cyclizine tartrate 50 mg/mL and morphine tartrate 15 mg/mL solution for injection |
Has concentration strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Cyclizine tartrate 50 mg/mL and morphine tartrate 15 mg/mL solution for injection |
Has concentration strength denominator value |
False |
1 |
Inferred relationship |
Some |
2 |
Atorvastatin 80 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Cerivastatin sodium 800 microgram oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Amisulpride 400 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Almotriptan malate 12.5 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Amprenavir 150 mg oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Amprenavir 50 mg oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Alendronic acid 70 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Nateglinide 180 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Nateglinide 120 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Nateglinide 60 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Capecitabine 500 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Capecitabine 150 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Aluminium hydroxide 500 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Aluminium hydroxide 475 mg oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
2 |
Atropine sulfate 600 microgram oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Alverine citrate 120 mg oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Alverine citrate 60 mg oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Nizatidine 150 mg oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Nizatidine 300 mg oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Misoprostol 200 microgram oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Omeprazole 20 mg oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Omeprazole 40 mg oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Omeprazole 10 mg oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Omeprazole 10 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Omeprazole 20 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Omeprazole 40 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Olsalazine sodium 250 mg oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Olsalazine sodium 500 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Budesonide 3 mg oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Balsalazide disodium 750 mg oral capsule |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |
Methylcellulose-450 500 mg oral tablet |
Has presentation strength denominator value |
False |
1 |
Inferred relationship |
Some |
1 |